Olema Pharmaceuticals, Inc. (OLMA)
7.48
+0.12
(+1.63%)
USD |
NASDAQ |
Nov 10, 10:01
Olema Pharmaceuticals Debt to Equity Ratio : 0.0085 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0085 |
| March 31, 2026 | 0.0082 |
| December 31, 2025 | 0.0088 |
| September 30, 2025 | 0.0146 |
| June 30, 2025 | 0.0138 |
| March 31, 2025 | 0.003 |
| December 31, 2024 | 0.0035 |
| September 30, 2024 | 0.0085 |
| June 30, 2024 | 0.0086 |
| March 31, 2024 | 0.0093 |
| December 31, 2023 | 0.0095 |
| September 30, 2023 | 0.0095 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.0124 |
| March 31, 2023 | 0.0131 |
| December 31, 2022 | 0.013 |
| September 30, 2022 | 0.013 |
| June 30, 2022 | 0.0131 |
| March 31, 2022 | 0.0115 |
| December 31, 2021 | 0.0116 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Puma Biotechnology, Inc. | 0.00 |
| SELLAS Life Sciences Group, Inc. | 0.0054 |
| ACADIA Pharmaceuticals, Inc. | 0.0518 |
| Alnylam Pharmaceuticals, Inc. | 0.8316 |
| Anika Therapeutics, Inc. | 0.1901 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 486.58M |
| Total Liabilities (Quarterly) | 56.01M |
| Shareholders Equity (Quarterly) | 430.56M |
| Current Ratio | 8.863 |
| Net Debt Paydown Yield | -0.05% |